Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-25
Closed -$7K 205
2022
Q4
$7K Hold
25
﹤0.01% 373
2022
Q3
$6K Sell
25
-525
-95% -$127K ﹤0.01% 401
2022
Q2
$134K Sell
550
-10
-2% -$2.45K 0.02% 242
2022
Q1
$135K Sell
560
-118
-17% -$27.1K 0.02% 248
2021
Q4
$153K Buy
678
+45
+7% +$9.5K 0.02% 257
2021
Q3
$135K Hold
633
0.02% 240
2021
Q2
$154K Hold
633
0.03% 205
2021
Q1
$157K Buy
+633
New +$151K 0.03% 199

Other funds holding AMGN

Sierra Capital's AMGN Position: Q1 2023 in Review

Sierra Capital sold out of Amgen (AMGN) in Q1 2023, closing a stake of 25 shares — an estimated $7K sold.

Sierra Capital first reported a position in AMGN in Q1 2021 and held it in 8 quarters. The position peaked at $157K in Q1 2021. 2,434 funds tracked by Wall St. Rank hold AMGN as of Q1 2023.

  • Sierra Capital reported no remaining Amgen position as of Q1 2023 after selling out during the quarter.
  • Sierra Capital sold 25 Amgen shares in Q1 2023, an estimated $7K.
  • Sierra Capital first reported a position in Amgen in Q1 2021 and held it in 8 quarters.
  • Sierra Capital's Amgen position peaked at $157K in Q1 2021.
  • 2,434 funds tracked by Wall St. Rank held Amgen as of Q1 2023.

Based on Sierra Capital's 13F filing for Q1 2023, filed 1 May 2023.